CELH Celsius Holdings
- 50.980
- +0.230+0.45%
- 51.100
- +0.120+0.24%
Celsius Holdings News
$100 Invested In Celsius Holdings 10 Years Ago Would Be Worth This Much Today
Celsius Holdings (NASDAQ:CELH) has outperformed the market over the past 10 years by 59.42% on an annualized basis producing an average annual return of 70.2%. Currently, Celsius Holdings has a
Roth MKM Maintains Celsius Holdings(CELH.US) With Buy Rating, Cuts Target Price to $75
Roth MKM analyst Sean McGowan maintains $Celsius Holdings(CELH.US)$ with a buy rating, and adjusts the target price from $87 to $75.According to TipRanks data, the analyst has a success rate of 47.1%
Roth MKM Remains a Buy on Celsius Holdings (CELH)
Express News | Celsius Holdings Inc : Roth Mkm Cuts Target Price to $75 From $87
Celsius Holdings's Options: A Look at What the Big Money Is Thinking
Financial giants have made a conspicuous bullish move on Celsius Holdings. Our analysis of options history for Celsius Holdings (NASDAQ:CELH) revealed 10 unusual trades.Delving into the details, we
Celsius (CELH.US) sees surge in Google search popularity, is it a good opportunity to buy at a low point after a sharp decline?
The stock price volatility of celsius holdings, the global leader of functional energy drinks, may continue to increase in the near future.
Celsius Holdings Is on Watch as Google Search Interest on the Beverage Stock Surges
Should You Believe in the Upside Potential of Celsius Holdings (CELH)
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” second quarter 2024 investor letter.
Celsius Holdings Options Spot-On: On July 15th, 95,869 Contracts Were Traded, With 372.5K Open Interest
On July 15th ET, $Celsius Holdings(CELH.US)$ had active options trading, with a total trading volume of 95,869 options for the day, of which put options accounted for 37.91% of the total transactions,
Celsius Market Share Under Pressure As Customers Trade Down -- Market Talk
1618 ET - Celsius Holdings may need an energy boost, after analysts at TD Cowen lower sales estimate and price target for the energy-drink maker, citing both slowing sales growth and market share
Trending Stocks Today: Autonomix Medical Shoots up 120.06%
July 15th - US stocks trending in regular trading hours.Gainers: $Autonomix Medical(AMIX.US)$ shoots up 120.06% to $1.36 with a turnover of $197.77 million. $AEON Biopharma(AEON.US)$ surges 68.57%
Express News | Celsius Holdings Shares Are Trading Lower After TD Cowen Maintained a Buy Rating on the Stock but Lowered the Price Target From $85 to $68
Why Celsius Holdings Stock Crashed 10% on Monday
Earnings season is upon us, and up on Wall Street analysts are placing their bets for who will beat — and who will disappoint investors this quarter.
TD Cowen Maintains Buy on Celsius Holdings, Lowers Price Target to $68
TD Cowen analyst Vivien Azer maintains Celsius Holdings (NASDAQ:CELH) with a Buy and lowers the price target from $85 to $68.
What's Going On With Celsius Holdings Stock?
Celsius Holdings Inc (NASDAQ:CELH) shares are trading lower Monday, adding to significant losses over the past two months. Here's a look at what's going on.What To Know: Celsius stock has been stuck
Will Celsius (CELH) Beat Estimates Again in Its Next Earnings Report?
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Celsius Holdings Inc. (CELH), which belongs to the Zacks Food - Miscellaneous industry.
Celsius Holdings Drops to a Five-month Low as Concerns Over Sales Growth Continue
Express News | Celsius Holdings Inc : TD Cowen Cuts Target Price to $68 From $85
UBS Maintains Celsius Holdings(CELH.US) With Buy Rating, Cuts Target Price to $70
UBS analyst Peter Grom maintains $Celsius Holdings(CELH.US)$ with a buy rating, and adjusts the target price from $92 to $70.According to TipRanks data, the analyst has a success rate of 59.2% and a
Celsius Holdings Inc. (CELH) Beats Stock Market Upswing: What Investors Need to Know
Celsius Holdings Inc. (CELH) closed at $58.90 in the latest trading session, marking a +0.65% move from the prior day.
Analysis
Price Target
No Data
